Senior Director, Commercial Excellence

About the Company

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit’s Team Is Inspired To Touch And Help Change Lives Through Summit’s Clinical Studies In The Field Of Oncology. Summit Has Multiple Global Phase 3 Clinical Studies, Including Non-small Cell Lung Cancer (NSCLC) HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.

About the Role

The Senior Director, Commercial Excellence leads the headquarters side of Commercial Operations. This role builds and governs the systems, rules, and processes that Marketing, Market Access, Market Research, Finance, and Compliance all work from. This is the backbone of Commercial Operations: people, process, data, technology (the commercial systems the teams use), training, reporting, and analytics. That covers Marketing Operations, commercial data and technology, commercial training, incentive compensation, territory design, CRM, targeting and segmentation, roster management, and field reporting standards. The test for this role is simple: if the answer should be the same in every region, it belongs here. This leader is the single point of operational accountability for the function and partners with Field Excellence, which deploys this infrastructure as the dedicated operational partner to Sales. This role is also the functional partner for the Oncology Nurse Educators and Regional Marketing Directors, who report to Marketing, and the Field Reimbursement Managers, who report to Market Access. Ivonescimab is an intravenous, buy-and-bill oncology product, and Summit has not commercialized a product before, so this leader builds the function rather than inheriting it. This role does not carry a sales quota, does not receive territory-based sales incentive compensation, and does not conduct promotional activity with customers. This position reports to the Executive Director, Commercial Operations. Direct reports are the Director, Marketing Operations; Director, Commercial Data & Technology; Director, Commercial Excellence; and Director, Field Learning & Development. Location: Princeton, NJ.

Responsibilities

• Set the strategy, operating model, and annual plan for the function, built to support the ivonescimab launch, future indications, and the wider portfolio
• Own the backbone of Commercial Operations (people, process, data, commercial technology, training, reporting, and analytics), and make sure each one is built, governed, and working for every function that relies on it
• Serve as the primary operational counterpart to Marketing, Market Access, and Market Research, and resolve cross-functional operational conflicts before they reach the field
• Serve as the functional partner for the Oncology Nurse Educators and Regional Marketing Directors (reporting to Marketing) and the Field Reimbursement Managers (reporting to Market Access), so their work runs on the same systems, definitions, and processes as the rest of the organization
• Lead Marketing Operations through the Director, Marketing Operations, including promotional review workflow, material fulfillment, meetings and events, speaker programs, agency management, and budget
• Oversee commercial data and technology through the Director, Commercial Data & Technology, including commercial data strategy, customer master data, the data warehouse, third-party data contracting, and the commercial systems the teams use, such as CRM. Set the business requirements for those systems and partner with IT on delivery
• Oversee commercial training through the Director, Field Learning & Development, including training strategy, the launch training plan, the learning management system, and onboarding
• Lead, through the Director, Commercial Excellence, incentive compensation design and governance, territory design and change governance, CRM business requirements and administration, targeting and segmentation methodology, and roster management and goal setting, so each one is compliant, accurate, and consistent nationally
• Set field reporting standards, working from the metric definitions owned by the Director, Commercial Analytics & Information
• Support Finance and Compliance on process governance, audit readiness, and Sunshine Act reporting
• Partner with the National Senior Director, Field Excellence so field patterns come back to headquarters and get fixed once, nationally
• Manage vendor relationships across all four teams, and build and own the annual budget for the function